Go to article: Home | Medicine in outer spaceGo to article: In this issueGo to article: ContentsGo to article: CSafeAPSGo to article: AgilentGo to article: BriefingGo to article: Industry newsGo to article: The pharma industry briefingGo to article: Pfeiffer VacuumGo to article: Mimotopes Company Insight Go to article: MimotopesGo to article: Allpack group agGo to article: CommentGo to article: Sandoz spin-off continues Novartis’ focus on innovationGo to article: High risk, high reward – the future of CAR-T therapy in CLLGo to article: bluebird bio bags landmark FDA approvals for gene therapiesGo to article: Covid-19 vaccine companies boosted with over 80% revenue growthGo to article: Urgent need to update Canada’s breast cancer screening guidelinesGo to article: The epidemiology of RSV changed in UK children during the pandemic Go to article: Zenatek Company Insight Go to article: BEA TechnologiesGo to article: In DepthGo to article: Medicine in outer space: drug development, manufacturing, and beyondGo to article: Oncology therapies dominate the orphan drug landscapeGo to article: How environmental factors could influence disease and drugsGo to article: Joining the dots: How gene regulatory network tools are unearthing drugsGo to article: Inflation drives pharma manufacturing focus on sustainability Go to article: What do remote assessments mean for sponsors?Go to article: CMO Moves: Regulatory catalysts for drug manufacturing-OctoberGo to article: TripletreeGo to article: In DataGo to article: Data analytics hiring levels in the pharma industry fell to a year-low in AugustGo to article: Pharma found it easier to fill cloud vacancies in Q2 of 2022Go to article: Pharma filings see a 56% increase in big data mentions since Q2 of 2021Go to article: Industrial automation hiring levels in pharma rose in August 2022Go to article: EventsGo to article: Next issue